| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $23.6M | -14.0% |
| R&D Expense | $42.1M | +5.8% |
| SG&A Expense | $54.9M | +59.9% |
| Operating Income | -$87.0M | -75.4% |
| Pre-tax Income | -$90.1M | -95.7% |
| Income Tax | $15.4M | — |
| Net Income | -$105.5M | -129.1% |
| EPS (Basic) | -$2.28 | -75.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.8M | -21.5% |
| Accounts Receivable | $10.2M | -36.9% |
| Inventory | $2.0M | -80.0% |
| Current Assets | $86.0M | -1.0% |
| Total Assets | $178.1M | +3.4% |
| Current Liabilities | $34.1M | -53.8% |
| Long-term Debt | $59.5M | +1074.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$69.7M | -107.7% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$22.2M | -27.4% |
| Financing Cash Flow | $82.1M | +188.5% |
| Free Cash Flow | -$69.7M | -105.9% |
| Total Liabilities |
| $138.5M |
| +25.3% |
| Stockholders' Equity | $39.7M | -35.9% |